Subscribe for Updates

Berkley Renewables Inc. is a growth-oriented venture firm pursuing opportunities in Renewable Energy, Life Sciences and the Oil & Gas sectors. The company is currently pursuing unique solar energy investments in Ontario, Canada. Berkley has diversified by purchasing an equity interest in RepliCel Life Sciences Inc., a publicly-traded, regenerative medicine company developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function.
July 26, 2017
Edmonton solar pioneer predicts "exponential growth" in Alberta
(more...)
June 30, 2017
Solar Flow-Through issues updates for Q1 2017
(more...)
April 4, 2017
Positive Results from RepliCel's RCS-01 Phase I Skin Trial are the Company's Most Compelling to Date
(more...)
March 28, 2017
Better panels, equipment and component integration still bringing rooftop costs down
(more...)
February 2, 2017
Companies Flocking to Japan for Biotech Deals
(more...)
January 8, 2017
After a year of restructuring, RepliCel is poised for multiple clinical trial data announcements and completion of medical device prototypes.
(more...)
December 22, 2016
Canada's solar market continues to evolve, with major growth expected in 2017
(more...)
August 31, 2016
The price of solar energy in the United States continues to tumble
(more...)
August 28, 2016
Renewable energy accounts for 43% of new US electricity generation capacity in the first half of 2016
(more...)
August 1, 2016
RepliCel's Cell Therapy for Pattern Baldness Proceeds to Clinical Trial Launch in Japan
(more...)
July 22, 2016
Solar Flow-Through Funds has released its Q2 2016 Investor Updates
(more...)
July 05, 2016
IESO to announce FIT 4 contract offers soon
(more...)
May 03, 2016
Solar Flow-Through Funds has issued Q1 2016 Investor Updates for its 2012, 2013 and 2014 LPs
(more...)
April 18, 2016
Developing countries turning to affordable solar energy
(more...)
April 7, 2016
Solar investment trumps oil and gas
(more...)